Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Motor Activity 32Breast Neoplasms 21Neoplasms 17Prostatic Neoplasms 11Obesity 8Colorectal Neoplasms 6Sarcopenia 5Pancreatic Neoplasms 5Lung Neoplasms 5Polycystic Ovary Syndrome 4Head and Neck Neoplasms 4Signs and Symptoms 3Multiple Myeloma 3Lymphedema 3Inflammation 3Fatigue 3Diabetes Mellitus, Type 2 3Colonic Neoplasms 3Brain Neoplasms 3Uterine Cervical Neoplasms 2Pharyngeal Neoplasms 2Overweight 2Osteoporosis, Postmenopausal 2Osteoporosis 2Lymphoma 2Leukemia, Myeloid, Acute 2Leukemia 2Laryngeal Neoplasms 2Insulin Resistance 2Endometrial Neoplasms 2

Interventions

Carboplatin 88pembrolizumab 85Paclitaxel 71Cyclophosphamide 63Capecitabine 38Doxorubicin 37Taxes 29130-nm albumin-bound paclitaxel 29Cisplatin 25Albumin-Bound Paclitaxel 22Epirubicin 21Drug Therapy 21Docetaxel 20sacituzumab govitecan 19olaparib 19camrelizumab 18atezolizumab 18Gemcitabine 17eribulin 16durvalumab 16Bevacizumab 16Radiotherapy 15toripalimab 14Specimen Handling 14Biopsy 13Everolimus 12Magnetic Resonance Spectroscopy 11apatinib 10Nivolumab 10talazoparib 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Triple Negative Breast Neoplasms × Resistance Training × Clear all
NCT07484776 2026-03-20

Metabolic Flexibility in Patients With Early Triple-negative Breast Cancer

Universidad Europea de Madrid

Phase NA Active not recruiting
40 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡